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rediction of Cardiovascular Outcomes With Left Atrial Size
s Volume Superior to Area or Diameter?
eresa S. M. Tsang, MD, FACC,*† Walter P. Abhayaratna, MBBS, FRACP,*† Marion E. Barnes, MS,†
oko Miyasaka, MD, PHD, FACC,*† Bernard J. Gersh, MB, CHB, DPHIL, FACC,*
ent R. Bailey, PHD,‡ Stephen S. Cha, MS,‡ James B. Seward, MD, FACC*†
ochester, Minnesota
OBJECTIVES We sought to compare left atrial (LA) volume to LA area and diameter for the prediction of
adverse cardiovascular outcomes.
BACKGROUND The incremental value of LA volume compared with LA area or diameter as a cardiovascular risk
marker has not been evaluated prospectively for patients with sinus rhythm or atrial fibrillation (AF).
METHODS Left atrial size was assessed with biplane LA volume, four-chamber LA area, and M-mode
dimension for 423 patients (mean age 71  8 years, 56% men) who were prospectively
followed for development of first AF, congestive heart failure, stroke, transient ischemic
attack, myocardial infarction, coronary revascularization, and cardiovascular death.
RESULTS Of the 317 subjects in sinus rhythm at baseline, 62 had 90 new events during a mean
follow-up of 3.5  2.3 years. All three LA size parameters were independently predictive of
combined outcomes (all p  0.0001). The overall performance for the prediction of
cardiovascular events was greatest for LA volume (area under the receiver operator
characteristic curve: indexed LA volume 0.71; LA area 0.64; LA diameter 0.59). A graded
association between the degree of LA enlargement and risk of cardiovascular events was only
evident for indexed LA volume. For subjects with AF, there was no association between LA
size and cardiovascular events.
CONCLUSIONS Left atrial volume is a more robust marker of cardiovascular events than LA area or diameter
in subjects with sinus rhythm. The predictive utility of LA size for cardiovascular events in
AF was poor, irrespective of the method of LA size quantitation. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.07747:1018–23) © 2006 by the American College of Cardiology Foundation
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Seft atrial (LA) volume is a more accurate measure of LA
ize than LA diameter (1,2), although both LA size param-
ters have been shown to be markers of cardiovascular risk
3–12). We are unaware of any prospective studies that
ompare the utility of the two LA size parameters for the
rediction of cardiovascular outcomes. Additionally, al-
hough LA volume has been demonstrated to be a robust
redictor of cardiovascular outcomes among patients with
inus rhythm in a number of retrospective studies
5,6,13,14), its prognostic utility for patients with atrial
brillation (AF) is unknown. In this prospective study, we
ssessed the clinical and echocardiographic correlations of
iplane LA volume and M-mode LA dimension and
ompared the utility of LA volume, area, and dimension for
he prediction of age-related cardiovascular outcomes in
atients with sinus rhythm and those with AF.
ETHODS
tudy population. This study was approved by the Mayo
oundation Institutional Review Board. Patients age 50
From the *Division of Cardiovascular Diseases and Internal Medicine, †Mayo
chocardiography Research Center, and the ‡Section of Biostatistics, Mayo Clinic,
ochester, Minnesota. Dr. Tsang is supported by the National Institutes of Health
National Institute on Aging), the American Heart Association, and the American
ociety of Echocardiography.a
Manuscript received May 9, 2005; revised manuscript received August 3, 2005,
ccepted August 9, 2005.ears referred for a general medical consultation were
nvited to participate if they had no history of congenital
eart disease, treatment with pacemaker implantation, val-
ular surgery, or cardiac transplantation.
linical data. Age, gender, height, weight, brachial blood
ressure, cardiac rhythm, and history of comorbid condi-
ions were recorded at enrollment. Definitions for all co-
ariates have been previously published (15).
Baseline cardiac rhythm was considered sinus if the
atient was in sinus rhythm at the time of echocardiography
nd had no prior history of atrial arrhythmias. Paroxysmal
F was defined by a history of AF episodes with intervening
inus rhythm. Because of the small number of paroxysmal
F patients, we did not try to differentiate whether conver-
ion to sinus rhythm in these patients was spontaneous or
ot. Permanent AF was defined by AF at baseline and the
ersistence of the arrhythmia without intervening sinus
pisodes.
chocardiographic data. Data for all echocardiographic
tudies were collected prospectively, and the parameters of
nterest were specified a priori. Measurements were ob-
ained at least two times for an average if the rhythm was
inus and at least three times if the rhythm was AF.
-mode LA dimension was measured as per the American
ociety of Echocardiography method (16). Single-plane
rea was evaluated from the four-chamber view of the left
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March 7, 2006:1018–23 LA Size and Cardiovascular Outcomestrium at end-ventricular systole, ensuring that there was no
oreshortening of the atrium. The area was then planime-
ered with the inferior LA border defined as the plane of the
itral annulus, excluding the confluence of the pulmonary
eins and the LA appendage.
Maximal biplane LA volume was measured in all patients
ith a modified biplane area-length method (17). This
ethod as well as the Simpson’s method of disc had both
een well-validated (18–20). Orthogonal apical views, most
ommonly apical four- and two-chamber views, were ob-
ained for determination of LA area and length (from the
iddle of the plane of the mitral annulus to the posterior
all). The apical long-axis view was used instead of the
able 1. Baseline Characteristics of the Study Population
Sinus
No CV Eve
(n  255
linical
Men, n (%) 132 (52)
Age (yrs) 70  8.
Body mass index (kg/m2) 28  5
Heart rate (beats/min) 68  12
Systolic blood pressure (mm Hg) 141  22
Diastolic blood pressure (mm Hg) 78  11
Pulse pressure (mm Hg) 64  20
History of myocardial infarction, n (%) 34 (13)
History of coronary artery disease, n (%) 71 (28)
Diabetes mellitus, n (%) 40 (16)
Current smoking, n (%) 20 (8)
History of dyslipidemia, n (%) 136 (53)
History of systemic hypertension, n (%) 151 (59)
History of stroke, n (%) 16 (6)
History of transient ischemic attack, n (%) 11 (4)
History of congestive heart failure, n (%) 25 (10)
History of valvular heart disease, n (%) 54 (21)
chocardiographic
LV ejection fraction (%) 62  10
LV end-diastolic septal wall thickness (mm) 11  2
LV end-diastolic posterior wall thickness (mm) 10  2
M-mode LA dimension (mm) 43  6
Indexed LA diameter (mm/m2) 23  3
LA diameter 40 mm (%) 31
4-chamber LA area (cm2) 22  4
LA volume (ml) 69  22
Indexed LA volume (ml/m2) 36  10
Indexed LA volume 28 ml/m2 (%) 16
Mitral E (m/s) 0.8  0.
Mitral A (m/s) 0.8  0.
Mitral E/A 1.0  0.
Mitral deceleration time (ms) 232  46
Abbreviations and Acronyms
AF  atrial fibrillation
CHF  congestive heart failure
LA  left atrial
LV  left ventricular
MI  myocardial infarction
TIA  transient ischemic attackV  cardiovascular; EF  ejection fraction; LA  left atrial; LV  left ventricular.wo-chamber view if the left atrium in the latter view
ppeared foreshortened. Specifically, the maximal LA
hamber area and length were measured at end ventricular
ystole, excluding the LA appendage and pulmonary veins.
eft atrial volume was calculated on the basis of the
lgorithm ([0.85  A1  A2]/L); where A1 is the four-
hamber LA area, A2 is the two-chamber or apical long axis
A area, and L is the average of the two lengths obtained from
he orthogonal views) and indexed to body surface area.
Indexed LA diameter, four-chamber LA area, and in-
exed LA volume were categorized according to current
merican Society of Echocardiography guidelines (21).
dditionally, we also assessed non-indexed LA diameter
ith 40 mm as the cut-off for normal on the basis of
ommon clinical practice.
Other echocardiographic variables, specified a priori,
ncluded left ventricular (LV) dimension at end-systole and
nd-diastole; LV septal and posterior end-diastolic wall
hickness; M-mode LV ejection fraction, mitral inflow
lling velocities (peak E and A); mitral inflow deceleration
ime; mitral isovolumic relaxation time; pulmonary venous
thm (n  317) Atrial Fibrillation (n  106)
CV Events
(n  62)
No CV Events
(n  71)
CV Events
(n  35)
38 (61) 40 (56) 26 (74)
73  7.5 74  7.5 75  6.8
28  5 29  6 27  3
67  14 72  16 66  16
137  19 133  20 142  22
75  11 75  13 77  11
61  15 58  19 45  17
18 (29) 7 (10) 9 (26)
33 (53) 18 (25) 16 (46)
15 (24) 11 (15) 9 (26)
7 (11) 2 (3) 2 (6)
42 (68) 40 (56) 18 (51)
43 (69) 42 (59) 26 (74)
5 (8) 7 (10) 4 (11)
3 (5) 10 (14) 5 (14)
12 (19) 18 (25) 11 (31)
24 (39) 37 (52) 16 (46)
56  17 60  12 50  17
11  2 11  2 11  2
11  2 11  2 11  2
46  5 52  10 52  8
24  3 26  6 27  5
4 7 3
24  5 28  6 30  6
85  31 126  95 127  77
44  14 64  48 65  45
4 8 3
0.9  0.3 1.0  0.4 1.0  0.4
0.9  0.3 n/a n/a
1.1  0.6 n/a n/a
226  61 222  85 207  62Rhy
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LA Size and Cardiovascular Outcomes March 7, 2006:1018–23ystolic and diastolic forward flow, and atrial reversal flow
elocities; and mitral annular motion septal velocity by
issue Doppler imaging (E’).
utcome ascertainment. All patients were prospectively
ollowed for development of new outcome events, which
ncluded AF, stroke, transient ischemic attack (TIA), myo-
ardial infarction (MI), coronary revascularization, conges-
ive heart failure (CHF), and cardiovascular death.
tatistical analysis. Continuous variables are presented as
eans  standard deviation. Categorical variables are dis-
layed as percentages. Differences between group means
ere evaluated with t tests (continuous variables) or chi-
quare analyses (categorical variables), as appropriate. Spear-
an correlations were used to assess the relation between
A size and other clinical and echocardiographic variables.
eceiver-operator characteristic curves were generated to
ssess the overall performance of the various LA size
arameters for the prediction of cardiovascular events.
ifferences in rates of cardiovascular events by LA size
Table 2. Correlates of Left Atrial Dimension a
r
Clinical
Age 0.2
Men 0.2
Body mass index 0.2
Body surface area 0.2
Heart rate 0.1
Systolic blood pressure 0.1
Diastolic blood pressure 0.0
Permanent AF 0.4
Paroxysmal AF 0.1
History of myocardial infarction 0.1
History of coronary artery disease 0.2
Diabetes mellitus 0.1
History of systemic hypertension 0.1
History of stroke 0.0
History of transient ischemic attack 0.1
History of CHF 0.2
History of valvular heart disease 0.2
Echocardiographic
LV ejection fraction 0.2
LV septal wall thickness 0.3
LV posterior wall thickness 0.3
LV end-diastolic dimension 0.3
LV end-systolic dimension 0.3
LV mass indexed by height 0.5
Mitral E 0.2
Mitral A 0.0
Mitral E/A 0.1
Mitral deceleration time 0.0
Mitral A duration 0.1
PV systolic forward flow 0.2
PV diastolic forward flow 0.2
PV atrial reversal flow 0.1
Tricuspid regurgitation velocity 0.3
RV systolic pressure 0.3
Not significantly associated with LA dimension or indexed L
reversal duration.AF  atrial fibrillation; CHF  congestive heart failure; P
abbreviations as in Table 1.ategories were examined with log-rank tests. Cox propor-
ional hazards modeling was used to determine the associ-
tion between LA dimension, LA area, and LA volume
ith future cardiovascular events, after adjusting for age,
ender, and other significant covariates.
ESULTS
aseline characteristics. A total of 423 patients (mean age
1 8 years, 56% men) met all study criteria and consented
o participate. Clinical indications for medical consultation
ncluded: dyspnea (24%); chest discomfort (23%); palpita-
ions, presyncope, and syncope (16%); and other reasons
11%). Of these, 317 (74%) were in sinus rhythm and had
o prior history of AF, 49 (12%) had a history of paroxysmal
F, and 57 (13%) had permanent AF. Characteristics of the
tudy population are outlined in Table 1, stratified by the
aseline cardiac rhythm.
ndexed Left Atrial Volume
imension Indexed LA Volume
p Value r p Value
0.0001 0.21 0.0001
0.0001 0.07 0.16
0.0001 0.0008 0.99
0.0001 n/a —
0.009 0.08 0.13
0.02 0.03 0.57
0.78 0.12 0.02
0.0001 0.45 0.0001
0.01 0.08 0.12
0.001 0.30 0.0001
0.0001 0.38 0.0001
0.01 0.16 0.002
0.0004 0.18 0.0009
0.09 0.22 0.0001
0.0004 0.14 0.008
0.0001 0.36 0.0001
0.0001 0.32 0.0001
0.0001 0.29 0.0001
0.0001 0.18 0.001
0.0001 0.22 0.0002
0.0001 0.29 0.0001
0.0001 0.30 0.0001
0.0001 0.49 0.0001
0.0001 0.37 0.0001
0.39 0.12 0.03
0.08 0.17 0.003
0.48 0.17 0.002
0.04 0.01 0.76
0.0001 0.11 0.0006
0.0001 0.33 0.0001
0.01 0.04 0.53
0.0001 0.27 0.0001
0.0001 0.32 0.0001
me: smoking history, dyslipidemia, pulmonary venous atrialnd I
LA D
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linical and echocardiographic correlates of LA dimension or
ndexed LA volume are listed in Table 2. Some parameters
ere significantly associated with one LA size parameter but
ot the other. Many baseline characteristics correlated signif-
cantly but not closely with LA size. For both LA dimension
nd indexed LA volume, LV mass indexed to height and
ermanent AF were the two strongest correlates.
rediction of cardiovascular events. PATIENTS IN SINUS
HYTHM. Over a mean follow-up period of 3.5 2.3 years,
2 patients had 90 new events (23 new AF, 8 strokes, 6
IAs, 12 MIs, 14 developed CHF, 26 coronary revascular-
zations, and 1 cardiovascular death). Of 317 subjects in
inus rhythm at baseline, 26% had a LA diameter 40 mm
nd therefore considered “normal.” According to the Amer-
can Society of Echocardiography guidelines (22), there
ere significant differences in the categorization of the LA
ize abnormality, depending on which LA size parameter
as used (Table 3). Patients who developed cardiovascular
vents had larger LA size at baseline, irrespective of the
ethod of quantitation (Table 1).
When the overall sensitivity and specificity of different
ethods of LA size quantitation using receiver operator
haracteristic curves were compared, the area under the
urve for indexed LA volume was greater than that of the
ther two methods, and its sensitivity was superior through-
ut the range of LA size (Fig. 1), even if coronary revascu-
igure 1. Receiver-operator characteristic curves for the overall perfor-
Table 3. Classification of Left Atrial Size Abn
Echocardiography Guidelines for Both Sinus a
Sinus (n 
Indexed
Diameter Area
Normal (%) 62 26
Mildly abnormal (%) 23 68
Moderately abnormal (%) 11 6
Severely abnormal (%) 4 0
See Tsang et al. (22).
AF  atrial fibrillation.ance of left atrial (LA) diameter, LA area, and indexed LA volume for
he prediction of cardiovascular events in patients with sinus rhythm.
F
farization was excluded as an end point (area under curve for
A volume 0.73 versus 0.70 and 0.66 for LA area and
iameter, respectively). There was a stepwise increase in risk
f cardiovascular events with each increment of LA volume
ategory (p  0.0001) (Fig. 2). Although there was an
verall association between indexed LA dimension and LA
rea and future cardiovascular events (both p  0.0001), a
raded association between increasing indexed LA diameter
r LA area and risk of events was not present. After adjustment
or age, gender, and other covariates, larger indexed LA
olume and LA dimension predicted higher risks of cardio-
ascular events (Table 4).
ATIENTS WITH ATRIAL FIBRILLATION. Among the 106
atients with paroxysmal or permanent AF at baseline, 35
ad 43 new events (10 strokes, 4 TIA, 5 MI, 16 CHF, and
coronary revascularization procedures) after a mean
ollow-up period of 3.0  2.4 years. Subjects with AF at
aseline were more likely than those with sinus rhythm to
evelop new events (36.8% vs. 19.6%, p  0.0001). Specif-
cally, AF patients had a higher incidence of stroke (9.4% vs.
.5%, p 0.002), TIA (3.8% vs. 1.9%, p 0.27), and CHF
15.1% vs. 4.4%, p  0.0001), but there was no difference
etween subgroups in the incidence of MI (4.7% vs. 3.8%,
 0.67) or coronary revascularization (7.6% vs. 8.3%, p 
.83). The difference in LA diameter, area, or indexed
olume between individuals with and without a cardiovas-
ular event during follow-up did not reach significance. For
hose with and without events, baseline median (interquar-
ile range) LA dimension was 51 mm (47 to 57 mm) versus
lity by the American Society of
F Subgroups
AF (n  106)
Indexed
Volume
Indexed
Diameter Area
Indexed
Volume
14 31 4 6
31 24 50 6
23 24 29 14
32 21 17 74orma
nd A
317)igure 2. Graded relationship between Kaplan-Meier cumulative event-
ree survival and categorical increment of indexed left atrial (LA) volume.
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LA Size and Cardiovascular Outcomes March 7, 2006:1018–231 mm (45 to 57 mm) (p 0.84); four-chamber LA area 30
m2 (26 to 35 cm2) versus 28 cm2 (24 tot 36 cm2) (p 
.49); and indexed LA volume 57 ml/m2 (46 to 78 ml/m2)
ersus 53 ml/m2 (37 to 68 ml/m2) (p  0.34). The overall
erformance of LA diameter or indexed volume to distin-
uish AF patients who did or did not have subsequent
ardiovascular events was poor, irrespective of whether
oronary revascularization was included as an end point. In
he AF subgroup, none of the LA size parameters was
ndependently predictive of the combined outcome when
djusted for age, gender, hypertension, diabetes, heart fail-
re, and myocardial infarction.
Even when warfarin therapy at baseline was considered, a
elationship between LA size and future events was not
etected. Of the 106 patients with AF, 52 (49%) were
eceiving warfarin at baseline (compared with 18 of 317
6%] of patients with sinus rhythm, p  0.0001). In
ultivariable models for the prediction of events in the AF
roup, warfarin therapy was not independently related to
he combined end point. For instance, in the multivariate
odel with clinical parameters (hypertension, diabetes,
ongestive heart failure, coronary artery disease, and ejection
raction), there seemed to be a trend toward higher risk of
vents associated with warfarin use (hazard ratio 1.89, p 
.063).
ISCUSSION
ndexed LA volume was a more sensitive risk marker of
uture cardiovascular events than LA diameter or area for
atients in sinus rhythm. The predictive utility of LA size
or future cardiovascular events was poor in AF patients,
egardless of the method used for quantitating LA size.
Dilatation of the left atrium, in the absence of organic
itral valve disease or history of AF, has been shown to
Table 4. Left Atrial Dimension and Indexed L
Multivariable Models Adjusting for Age, Gend
Cardiovascular Events in Patients With Sinus
%
U
Hazards R
Left atrial dimension
40 mm 74 9.8
Indexed left atrial diameter
Mildly increased 23 2.9
Moderately increased 11 4.1
Severely increased 4 2.6
Left atrial area
Mildly increased 68 3.0
Moderately increased 6 6.2
Severely increased — —
Indexed left atrial volume
Mildly increased 31 2.3
Moderately increased 23 3.5
Severely increased 32 9.0
*Multivariate model: adjusted for age, gender, left ventricu
mellitus, myocardial infarction, and valvular heart disease; †p v
variable.eflect the burden of cardiovascular disease (22–24). During pentricular diastole, the left atrium is exposed to the
ressures of the left ventricle. With increased stiffness of the
eft ventricle, LA pressure rises to maintain adequate LV
lling, and the increased atrial wall tension leads to chamber
ilatation and stretch of the atrial myocardium.
Although M-mode LA dimension is easy to acquire, its
alidity has recently been challenged (1). Because the left
trium is an asymmetrical cavity, LA size is more accurately
eflected by a measurement of volume rather than area or a
inear dimension. Furthermore, LA dilatation might not be
venly distributed in all planes, and measurement of antero-
osterior dimension is likely to be insensitive to changes in
A size.
In the presence of AF, however, our findings suggest that
A enlargement needs to be interpreted with caution. The
echanism responsible for the lack of an association be-
ween LA size and cardiovascular events in the presence of
F cannot be fully determined in this study. In addition to
he various mechanisms that lead to increased LV filling
ressures and thus LA enlargement in sinus patients, AF
atients might also develop progressive and refractory LA
ilation from tachycardia-induced atrial myopathy (20) with
dvanced remodeling of the atrium with replacement fibro-
is, independent of increased LV filling pressures. The more
revalent use of warfarin in the AF group could not explain
he lack of association between LA size and risk for
evelopment of cardiovascular events. Rather than exerting
protective effect with lowering the risk of combined
vents, warfarin use seemed to be associated with a nonsig-
ificant trend toward a higher risk for such events. This was
ost likely secondary to a selection process; that is, patients
eceiving warfarin at baseline were at higher risk for cardio-
ascular events. Admittedly, the relatively small sample of
F patients in this study might not have provided sufficient
trial Volume in Unadjusted, and
nd Other Covariates for the Prediction of
hm at Baseline
usted Adjusted*
p Value† Hazards Ratio p Value†
0.002 9.0 0.003
0.0001 3.0 0.001
2.9
3.4
0.001 2.0 0.02
3.9
—
0.0001 2.0 0.001
3.2
6.6
ection fraction, history of systemic hypertension, diabetes
fers to the significance of the variable treated as a continuouseft A
er, a
Rhyt
nadj
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lar ejower to detect an association between LA size and out-
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March 7, 2006:1018–23 LA Size and Cardiovascular Outcomesomes in this subgroup. Nonetheless, LA enlargement in
F patients does not seem to have the same robustness for
rediction of cardiovascular outcomes as it does in sinus
hythm.
tudy limitations. The study population is referral-based,
nd the extent to which the data can be generalized to other
opulation groups is not known. The contribution of
edical therapy to change in LA size was not considered in
his study, given the relatively small sample size, the diverse
ange of reasons for which the patients were seen, and the
ifferences in dosage and duration of various therapies.
onclusions. Indexed LA volume is a more robust cardio-
ascular risk marker than LA area or diameter in patients
ho are in sinus rhythm; however, in patients with AF, the
redictive utility of LA size for future cardiovascular events
eemed unsatisfactory, regardless of the method of LA
uantitation. Future studies to include larger number of AF
atients for further evaluation will be warranted.
eprint requests and correspondence: Dr. Teresa S. M. Tsang,
ivision of Cardiovascular Diseases and Internal Medicine, Mayo
linic, 200 First Street SW, Rochester, Minnesota 55905. E-mail:
sang.teresa@mayo.edu.
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